Inventor · disambiguated record
Camil Sayegh
Also filed as: SAYEGH CAMIL · SAYEGH CAMIL E · SAYEGH CAMIL ELIE
5 granted patents·6 pending applications·9 citations·filing 2016–2024
70Inventor score
Top patents by PatentIndex Score
11 records- 0191US12060346B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2023·Granted Aug 13, 2024·1 cites·53 claims
- 0291US11618746B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2019·Granted Apr 4, 2023·6 cites·28 claims
- 0382US12281102B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2021·Granted Apr 22, 2025·1 cites·38 claims
- 0482US12116343B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2021·Granted Oct 15, 2024·1 cites·33 claims
- 0578US2025042878A1Inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 0653US2023014907A1Inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 0750US2022370548A1Neurological disease treatment with complement inhibitorsRA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0848US2023115176A1Complement Modulators and Related MethodsRA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0946US2019119282A1Imidazopyridazines useful as inhibitors of the par-2 signaling pathwayVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 1041US10030024B2Imidazopyridazines useful as inhibitors of the PAR-2 signaling pathwayVERTEX PHARMA·Filed 2016·Granted Jul 24, 2018·0 cites·23 claims
- 1131US2018057505A1Bicyclic heteroaryl compounds useful as inhibitors of the par-2 signaling pathwayVERTEX PHARMA·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →